- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 04-08-2026: Press Release
04-08-2026 | 02:20 pm
04-08-2026 | 02:20 pm
Alembic Pharma reported strong Q1 results. Revenue rose 26% to Rs 2150 Cr, PAT up 12% to Rs 173 Cr. EBITDA margin at 24%. US Formulation surged 49% with 7 launches, India Branded grew 7% (3 new products), and API business was up 33%. Received 10 ANDA approvals.
No comments yet. Be the first to comment!